The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The ICH E14 guidance on how to clinically assess a new drug's liability to prolong the QT interval was adopted in May 2005. A centre‐piece of the guidance was the establishment of one single trial, the ‘thorough QT/QTcstudy’, intended to confidently identify drugs that may cause QT prolongation. Initially perceived as a great challenge, this study has rapidly become a standard component of all clinical development programs for new molecular entities. The study is normally conducted in healthy volunteers, includes both a positive and a negative (placebo) control and is stringently powered to exclude an effect on the QTc interval exceeding 10 ms. The E14 guidance was intentionally not very prescriptive and allowed sponsors and service providers to explore new methodologies. This has allowed for a rapid development of new methods during the first years after the guidance's implementation, such as computer‐assisted algorithms for QT measurements. Regulators have worked in close collaboration with pharmaceutical industry to set standards for the design and conduct of the ‘thorough QT/QTc study’, which therefore has evolved as a key component of cardiac safety assessment of new drugs. This paper summarizes the requirements on the ‘thorough QT/QTc study’ with emphasis on the standard that has evolved based on interactions between regulators and sponsors and the experience from a large number of completed studies. This article is part of a themed section on QT safety. To view this issue visit http://www3.interscience.wiley.com/journal/121548564/issueyear?year=2010
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Drug induced QT prolongation and torsades de pointes
Yap, Y. G., & Camm, A. J. (2003) · Heart · doi:10.1136/heart.89.11.1363 · Cited by 958
Burke, J. H., Ehlert, F. A., Kruse, J. T., Parker, M. A., Goldberger, J. J., & Kadish, A. H. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00707-2 · Cited by 189
Cited by
Laverty, H., Benson, C., Cartwright, E., Cross, M., Garland, C., Hammond, T., Holloway, C., McMahon, N., Milligan, J., Park, B., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01255.x · Cited by 363
Drug-induced QT interval prolongation: mechanisms and clinical management
Nachimuthu, S., Assar, M. D., & Schussler, J. M. (2012) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098612454283 · Cited by 307
Curtis, M. J., Hancox, J. C., Farkas, A., Wainwright, C. L., Stables, C. L., Saint, D. A., Clements-Jewery, H., Lambiase, P. D., Billman, G. E., Janse, M. J., et al. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.04.008 · Cited by 286
Vieweg, W. V. R., Hasnain, M., Howland, R. H., Hettema, J. M., Kogut, C., Wood, M. A., & Pandurangi, A. K. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.12.002 · Cited by 270
Detection of QTc effects in small studies—Implications for replacing the thorough QT study
Ferber, G., Zhou, M., & Darpo, B. (2015) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12227 · Cited by 59
Metadata
- Authors
- Darpo, B.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2010-01
- Volume
- 159
- Issue
- 1
- Pages
- 49-57
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1909306694
- Cited by
- 141
- References
- 3
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance. https://app.cochat.ai/papers/10.1111/j.1476-5381.2009.00487.x
- The paper
- Darpo, B. (2010). The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2009.00487.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.